Brief: Fresh Tracks Therapeutics Reports Third Quarter 2022 Financial Results And Provides Corporate Update
Nov 10 (Reuters) - Fresh Tracks Therapeutics Inc
FRTX.O :
* FRESH TRACKS THERAPEUTICS REPORTS THIRD QUARTER
2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* FRESH TRACKS THERAPEUTICS INC- CASH AND CASH EQUIVALENTS
OF
$11.3 MILLION AS OF SEPTEMBER 30, 2022
* FRESH TRACKS THERAPEUTICS INC - QTRLY LOSS PER SHARE $2.07
Source text for Eikon: ID:nGNXbS1m3z
Further company coverage: FRTX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx